SBIR/STTR Research Award

Marketability of a technology based intervention to increase HPV vaccination

Award identifier 07f7625f60a39d9096a0e15fa4ef827c974638f67610b2356393f7a20667c373Awarding agency Department of Health and Human Services · Centers for Disease Control and Prevention

Award amount

$1,294,930

Program and phase

SBIR · Phase II

Award year

2016

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Centers for Disease Control and Prevention
Recipient company
REAL PREVENTION LLC
Proposal award date
2016-09-30
Contract end date
2018-09-29
UEI
DALPEA4VNNJ3
Solicitation number
PA15-269
Topic code
NCCDPHP

Research abstract

The purpose of this Phase II research project is to evaluate and market an innovative health message intervention to increase uptake of the human papillomavirus HPV vaccine and reduce women s cervical cancer risk through partnership with Planned Parenthood The overall aim is to reach a broad population through Planned Parenthood the nation s leading sexual and reproductive health care center especially among low socioeconomic status SES and historically underserved populations Despite an overall increase in vaccination and reduction in HPV related infections in younger populations targeted by previous health promotion efforts young adult women who are recommended for vaccination demonstrate much lower vaccination rates and higher rates of infection In a recent Phase I grant we developed and demonstrated the usability and feasibility of an innovative culturally grounded technology based narrative intervention that delivers decision narratives in the form of videos via a health kiosk an underutilized communication strategy for reaching less involved audiences This brief low cost easily implementable intervention doubled the uptake of the vaccine in a separate pilot study The proposed Phase II project will Complete development of the intervention Evaluate its effectiveness through a randomized clinical trial and Prepare the product for the market To accomplish these aims we will develop the intervention for implementation in waiting rooms as part of check in procedures and exam rooms as part of intake Our pilot research suggests these are both viable implementation strategies Development includes programing and installing tablets to accomplish these tasks Aim We will then conduct the evaluation study in six Planned Parenthood clinics in southeastern Pennsylvania Aim In the waiting room condition women will complete check in via a tablet and that information used to identify and recruit eligible volunteers unvaccinated women aged In the exam room condition the intervention will be viewed on a tablet as part of the intake procedure facilitated by a nurse or other designated clinic staff Eligible women will be consented complete a pretest and then randomized to view the brief intervention or attention control messages via the tablet After viewing the messages they will complete a short posttest Participants will receive follow up texts emails reminding them to vaccinate as well as texts emails with links that allow them to complete posttest surveys at and months Finally we will prepare the intervention for the market that includes not only Planned Parenthood but other clinics that are currently served by the project partners as well as the broader market for HPV vaccination Aim In summary the proposed communication strategy has wide reaching implications not only for reducing cancer risk but more broadly for designing brief and easily implemented prevention messages across many domains of public health The research will also close the health disparities gap in minority underserved young adult women s access to preventive health care The overall goal of this SBIR Phase II project is to reduce cancer rates by marketing a brief easily implemented technology based intervention that increases human papillomavirus HPV vaccination among Planned Parenthood and other clients The intervention s innovative technology allows for our narrative videos to be presented along will reminder texts It will be evaluated in waiting and exam rooms and promises to overcome vaccination barriers among high risk but underserved low SES and minority populations

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

11 SBIR/STTR records share this UEI (2015–2023). Reported award amounts total $7,477,096. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.